» Articles » PMID: 27733675

Stroke-induced Immunodepression and Dysphagia Independently Predict Stroke-associated Pneumonia - The PREDICT Study

Abstract

Stroke-associated pneumonia is a frequent complication after stroke associated with poor outcome. Dysphagia is a known risk factor for stroke-associated pneumonia but accumulating evidence suggests that stroke induces an immunodepressive state increasing susceptibility for stroke-associated pneumonia. We aimed to confirm that stroke-induced immunodepression syndrome is associated with stroke-associated pneumonia independently from dysphagia by investigating the predictive properties of monocytic HLA-DR expression as a marker of immunodepression as well as biomarkers for inflammation (interleukin-6) and infection (lipopolysaccharide-binding protein). This was a prospective, multicenter study with 11 study sites in Germany and Spain, including 486 patients with acute ischemic stroke. Daily screening for stroke-associated pneumonia, dysphagia and biomarkers was performed. Frequency of stroke-associated pneumonia was 5.2%. Dysphagia and decreased monocytic HLA-DR were independent predictors for stroke-associated pneumonia in multivariable regression analysis. Proportion of pneumonia ranged between 0.9% in the higher monocytic HLA-DR quartile (≥21,876 mAb/cell) and 8.5% in the lower quartile (≤12,369 mAb/cell). In the presence of dysphagia, proportion of pneumonia increased to 5.9% and 18.8%, respectively. Patients without dysphagia and normal monocytic HLA-DR expression had no stroke-associated pneumonia risk. We demonstrate that dysphagia and stroke-induced immunodepression syndrome are independent risk factors for stroke-associated pneumonia. Screening for immunodepression and dysphagia might be useful for identifying patients at high risk for stroke-associated pneumonia.

Citing Articles

Oral hygiene is independently associated with early stroke-associated pneumonia in hospitalized patients with ischemic stroke: An observational study.

Yang X, Lu Y, Chen H, Wei J, He J, Zhang J Medicine (Baltimore). 2025; 104(10):e41758.

PMID: 40068034 PMC: 11902991. DOI: 10.1097/MD.0000000000041758.


Early Predictive Value of the Glucose-to-Lymphocyte Ratio for the Occurrence of Stroke-Associated Pneumonia.

Zhou F, Ma L, Li M, Li H, Yang H, Xu Y Brain Behav. 2025; 15(3):e70404.

PMID: 40059438 PMC: 11891278. DOI: 10.1002/brb3.70404.


Prognostic nutritional index (PNI) as an influencing factor for in-hospital mortality in patients with stroke-associated pneumonia: a retrospective study.

Xie K, Zhang C, Nie S, Kang S, Wang Z, Zhang X PeerJ. 2025; 13:e19028.

PMID: 40028204 PMC: 11871890. DOI: 10.7717/peerj.19028.


Individualized prediction of stroke-associated pneumonia for patients with acute ischemic stroke.

Zhang L, Wang Q, Li Y, Fang Q, Tang X Front Neurol. 2025; 16:1505270.

PMID: 39990262 PMC: 11843556. DOI: 10.3389/fneur.2025.1505270.


A novel prediction method for intracerebral hemorrhage-associated pneumonia: A single center analysis.

Li Y, Chen Y, Yao M, Wang G, Pan Y, Chen H PLoS One. 2025; 20(2):e0318455.

PMID: 39977414 PMC: 11841904. DOI: 10.1371/journal.pone.0318455.


References
1.
Cook N . Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007; 115(7):928-35. DOI: 10.1161/CIRCULATIONAHA.106.672402. View

2.
Worthmann H, Tryc A, Dirks M, Schuppner R, Brand K, Klawonn F . Lipopolysaccharide binding protein, interleukin-10, interleukin-6 and C-reactive protein blood levels in acute ischemic stroke patients with post-stroke infection. J Neuroinflammation. 2015; 12:13. PMC: 4307994. DOI: 10.1186/s12974-014-0231-2. View

3.
Koennecke H, Belz W, Berfelde D, Endres M, Fitzek S, Hamilton F . Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unit. Neurology. 2011; 77(10):965-72. DOI: 10.1212/WNL.0b013e31822dc795. View

4.
Meisel A, Smith C . Prevention of stroke-associated pneumonia: where next?. Lancet. 2015; 386(10006):1802-4. DOI: 10.1016/S0140-6736(15)00127-0. View

5.
Westendorp W, Vermeij J, Zock E, Hooijenga I, Kruyt N, Bosboom H . The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial. Lancet. 2015; 385(9977):1519-26. DOI: 10.1016/S0140-6736(14)62456-9. View